Abstract
The trend within the pharmaceutical industry towards large-molecule biologic drug substances is well documented. Due to the fragile nature of these compounds, they often need either cold-chain logistics or reconstitution prior to administration. Innovation in reconstitution devices and in formulations has been stifled by the inability of conventional powder handling systems to dispense small and precise amounts of reconstitution powders aseptically.
This paper, from Tom Bailey, Managing Director, and Dave Seaward, Projects Director, both of 3P Innovation, describes how the company's innovative gravimetric Fill2WeightTM system overcomes these technical challenges to enable advances in both formulations and parenteral device design.
